The striate sign: peritumoural perfusion pattern of infiltrative primary and recurrent gliomas

作者: Stella Blasel , Kea Franz , Michel Mittelbronn , Gerald Morawe , Alina Jurcoane

DOI: 10.1007/S10143-010-0248-7

关键词:

摘要: MR perfusion depicts angiogenesis as a key factor for growth and malignancy in gliomas by means of increased regional cerebral blood volume (rCBV). The rCBV increase is not limited to the tumour area, but may also produce stripe-like pattern peritumoural that we defined “striate sign”. We evaluated if prior radiochemotherapy influences values adjacent malignant comparing treated recurrent with untreated gliomas. Ninety-three patients primary or WHO grades II–IV glial tumours underwent T2*-weighted dynamic susceptibility-weighted contrast-enhanced (DSC)-MRI. Differences normalised rCBVmax were using Kruskal−Wallis analysis post hoc tests. number cases showing hot spot (rCBVmax) and/or striate (striate sign) was assessed Fisher’s exact test. Significance level determined p < 0.05. Normalised rCBV, sign significantly lower (rCBV = 3.24 ± 1.22, 5.05 2.27 10/24) compared grade IV 4.44 1.39, 7.31 3.0 17/21, respectively). There fewer III than transformed II tumours. degree around differ between previously These differences might be due post-therapeutic changes tumour-associated microvasculature radiochemotherapy. Spectroscopic imaging provide further insights into biology.

参考文章(61)
M H Lev, B R Rosen, Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clinics of North America. ,vol. 9, pp. 309- 331 ,(1999)
M. Principi, M. Italiani, A. Guiducci, I. Aprile, M. Muti, G. Giulianelli, P. Ottaviano, Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas Neuroradiology. ,vol. 45, pp. 205- 211 ,(2003) , 10.1007/S00234-002-0937-1
M. Krause, J. Fritzmann, P. Rodemann, M. Baumann, Interaktionen von EGFR- und VEGFR-Inhibitoren mit Chirurgie und Strahlentherapie Onkologe. ,vol. 13, pp. 67- 72 ,(2007) , 10.1007/S00761-006-1148-X
E. Tessa Hedley-Whyte, Harry N. Antoniades, Janine Neville-Golden, Stephen P. Naber, Hubert J. Wolfe, Marius Maxwell, Theofanis Galanopoulos, Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Research. ,vol. 51, pp. 1345- 1351 ,(1991)
Pieter Wesseling, Dirk J. Ruiter, and Peter C. Burger, Angiogenesis in brain tumors: pathobiological and clinical aspects Journal of Neuro-oncology. ,vol. 32, pp. 253- 265 ,(1997) , 10.1023/A:1005746320099
Ken Samoto, Tadahisa Shono, Mayumi Ono, Michihiko Kuwano, Masashi Fukui, Kiyonobu Ikezaki, Kimitoshi Kohno, Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Research. ,vol. 55, pp. 1189- 1193 ,(1995)
M. Barinaga, Cancer Drugs Found to Work in New Way Science. ,vol. 288, pp. 245- 245 ,(2000) , 10.1126/SCIENCE.288.5464.245A
J. Marx, Angiogenesis. A boost for tumor starvation. Science. ,vol. 301, pp. 452- 454 ,(2003) , 10.1126/SCIENCE.301.5632.452
M.-A. Weber, M. Vogt-Schaden, O. Bossert, F. L. Giesel, H.-U. Kauczor, M. Essig, MR-Perfusions- und spektroskopische Bildgebung bei WHO-Grad-II-Astrozytomen Radiologe. ,vol. 47, pp. 812- 818 ,(2007) , 10.1007/S00117-006-1406-3
Judah Folkman, Birgit M. Kräling, Catherine E. Butterfield, Blair Marshall, Timothy Browder, Michael S. O’Reilly, Bin Shi, Antiangiogenic Scheduling of Chemotherapy Improves Efficacy against Experimental Drug-resistant Cancer Cancer Research. ,vol. 60, pp. 1878- 1886 ,(2000)